AtriCure, Inc. (ATRC) Misses Q2 EPS by 1c, Revenue Falls Inline
Tweet Send to a FriendGet Alerts ATRC Hot Sheet
Price: $9.07 +0.89%
Financial Fact:
Selling, general and administrative expenses: 12.38M
Today's EPS Names:
DSX, REDF, REX, More
Financial Fact:
Selling, general and administrative expenses: 12.38M
Today's EPS Names:
DSX, REDF, REX, More
Trade ATRC Now!
AtriCure, Inc. (NASDAQ: ATRC) reported Q2 EPS of ($0.06), $0.01 worse than the analyst estimate of ($0.05). Revenue for the quarter came in at $16.8 million versus the consensus estimate of $16.21 million.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- NetApp (NTAP) Tops Q4 EPS by 1c; Boosts Buyback, Plans Job Cuts, Initiates Dividend
- Booz Allen Hamilton (BAH) Tops Q4 EPS by 3c; Guides In-Line FY14 EPS
- Rexnord (RXN) Misses Q4 EPS by 7c; Issues Light Q1 Outlook
Create E-mail Alert Related Categories
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
